Abstract:Backgrounds Long non-coding RNAs (lncRNAs) are essential factors that regulate tumor development and metastasis via diverse molecular mechanisms in a broad type of cancers. However, the pathological roles of lncRNAs in gallbladder carcinoma (GBC) remain largely unknown. Here we discovered a novel lncRNA termed lncRNA Highly expressed in GBC (lncRNA-HGBC) which was upregulated in GBC tissue and aimed to investigate its role and regulatory mechanism in the development and progression of GBC. Methods The expression level of lncRNA-HGBC in GBC tissue and different cell lines was determined by quantitative real-time PCR. The full length of lncRNA-HGBC was obtained by 5 ' and 3 ' rapid amplification of the cDNA ends (RACE). Cellular localization of lncRNA-HGBC was detected by fluorescence in situ hybridization (FISH) assays and subcellular fractionation assay. In vitro and in vivo assays were preformed to explore the biological effects of lncRNA-HGBC in GBC cells. RNA pull-down assay, mass spectrometry, and RNA immunoprecipitation (RIP) assay were used to identify lncRNA-HGBC-interacting proteins. Dual luciferase reporter assays, AGO2-RIP, and MS2-RIP assays were performed to verify the interaction between lncRNA-HGBC and miR-502-3p. Results We found that lncRNA-HGBC was upregulated in GBC and its upregulation could predict poor survival. Overexpression or knockdown of lncRNA-HGBC in GBC cell lines resulted in increased or decreased, respectively, cell proliferation and invasion in vitro and in xenografted tumors. LncRNA-HGBC specifically bound to RNA binding protein Hu Antigen R (HuR) that in turn stabilized lncRNA-HGBC. LncRNA-HGBC functioned as a competitive endogenous RNA to bind to miR-502-3p that inhibits target gene SET. Overexpression, knockdown or mutation of lncRNA-HGBC altered the inhibitory effects of miR-502-3p on SET expression and downstream activation of AKT. Clinically, lncRNA-HGBC expression was negatively correlated with miR-502-3p, but positively correlated with SET and HuR in GBC tissue. Conclusions Our study demonstrates that lncRNA-HGBC promotes GBC metastasis via activation of the miR-502-3p-SET-AKT cascade, pointing to lncRNA-HGBC as a new prognostic predictor and a therapeutic target.

Upregulation of Long Non-Coding RNA LINC00152 by SP1 Contributes to Gallbladder Cancer Cell Growth and Tumor Metastasis Via PI3K/AKT Pathway.

Long non-coding RNA LINC00152 promotes gallbladder cancer metastasis and epithelial–mesenchymal transition by regulating HIF-1α via miR-138

Retraction: ‘long Non-Coding RNA LINC00152 Promotes Gallbladder Cancer Metastasis and Epithelial-Mesenchymal Transition by Regulating HIF-1α Via Mir-138’

Long Non-Coding RNA LINC01410 Promoted Tumor Progression Via the ErbB Signaling Pathway by Targeting STAT5 in Gallbladder Cancer.

LncRNA-HGBC Stabilized by HuR Promotes Gallbladder Cancer Progression by Regulating Mir-502-3p/set/akt Axis

LncRNA-PAGBC Acts As a Microrna Sponge and Promotes Gallbladder Tumorigenesis.

Long Noncoding RNA NEAT1 Upregulates Survivin and Facilitates Gallbladder Cancer Progression by Sponging Microrna-335

Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer

Long noncoding RNA lncGALM increases risk of liver metastasis in gallbladder cancer through facilitating N‐cadherin and IL‐1β‐dependent liver arrest and tumor extravasation

SP1-Induced Upregulation of lncRNA LINC00659 Promotes Tumour Progression in Gastric Cancer by Regulating miR-370/AQP3 Axis

Long Noncoding RNA PVT1 Promoted Gallbladder Cancer Proliferation by Epigenetically Suppressing Mir-18B-5p Via DNA Methylation

Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells

Upregulation of PAIP1 promotes the gallbladder tumorigenesis through regulating PLK1 level

Retracted: Long Non‐coding RNA Linc‐ITGB1 Knockdown Inhibits Cell Migration and Invasion in GBC‐SD/M and GBC‐SD Gallbladder Cancer Cell Lines

Upregulation of Long Non-Coding RNA HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition in Gallbladder Carcinoma

LINC00662 Promotes Aggressive Traits by Modulating OCT4 Expression through miR-335-5p in Gallbladder Cancer Cells

Long Intergenic Non-Coding Rna 00152 Promotes Tumor Cell Cycle Progression By Binding To Ezh2 And Repressing P15 And P21 In Gastric Cancer

LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.

Long Non-Coding RNA MINCR Promotes Gallbladder Cancer Progression Through Stimulating EZH2 Expression.

LASP-1 Induces Proliferation, Metastasis and Cell Cycle Arrest at the G2/M Phase in Gallbladder Cancer by Down-Regulating S100P Via the PI3K/AKT Pathway

Long Non-Coding RNA CCAT1 Promotes Gallbladder Cancer Development Via Negative Modulation of Mirna-218-5p.